Skip to main content
Erschienen in: Medical Oncology 4/2014

01.04.2014 | Original Paper

Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents

verfasst von: Cristina Meazza, Roberto Luksch, Primo Daolio, Marta Podda, Alessandro Luzzati, Alessandro Gronchi, Antonina Parafioriti, Lorenza Gandola, Paola Collini, Andrea Ferrari, Michela Casanova, Monica Terenziani, Filippo Spreafico, Daniela Polastri, Veronica Biassoni, Elisabetta Schiavello, Emilia Pecori, Maura Massimino

Erschienen in: Medical Oncology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

The survival of patients with axial skeletal or pelvic osteosarcoma (OS) remains poor, and the management of these patients is challenging. The object of this study is a cohort of unselected patients aged < 19 years with primary high-grade pelvic/axial OS. Patients were treated with high-dose methotrexate, doxorubicin, cisplatin, ifosfamide followed or preceded by local treatment (surgery and/or radiotherapy). Twenty patients aged 3–19 years were treated. Eight patients had pelvic OS, 8 axial OS and 4 mandible/maxilla OS. All patients received chemotherapy, after which necrosis was evaluable in 9 patients (≥90 % in 3). Sixteen patients underwent surgery. Radiotherapy was administered to 8 patients (total dose 34–60 Gy). The median follow-up was 35 months (8–276), and the 5-year disease-free survival and overall survival rates were 37 and 40 %, respectively. Six patients were alive at the time of this report: 2 with pelvic OS (both responded well to chemotherapy, one underwent hemipelvectomy and the other had non-radical surgery plus radiotherapy); 1 with axial and multicentric OS (with a good histological response and radical surgery); 3 with mandible/maxilla OS. Two patients died of secondary tumors (one bone and one breast cancer). It is worth noting that 4 patients had a p53 mutation: 1 is alive, 2 died of their OS, 1 of breast cancer. Adequacy of local treatment and pathological response influenced the prognosis for axial OS, which remained dismal. A high incidence of p53 mutation emerged in our series of patients.
Literatur
1.
Zurück zum Zitat Ferrari S, Smeland S, Mercuri M, Bertoni F, et al. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol. 2005;23:8845–52.PubMedCrossRef Ferrari S, Smeland S, Mercuri M, Bertoni F, et al. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol. 2005;23:8845–52.PubMedCrossRef
2.
Zurück zum Zitat Meyers PA, Schwartz CL, Krailo MD, et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival: a report from the Children’s Oncology Group. J Clin Oncol. 2008;26:633–8.PubMedCrossRef Meyers PA, Schwartz CL, Krailo MD, et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival: a report from the Children’s Oncology Group. J Clin Oncol. 2008;26:633–8.PubMedCrossRef
3.
Zurück zum Zitat Fuchs N, Bielack SS, Epler D, et al. Long-term results of the Co-operative German-Austrian-Swiss Osteosarcoma Study Group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998;9:893–9.PubMedCrossRef Fuchs N, Bielack SS, Epler D, et al. Long-term results of the Co-operative German-Austrian-Swiss Osteosarcoma Study Group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998;9:893–9.PubMedCrossRef
4.
Zurück zum Zitat Meyers P, Heller G, Healey JH, et al. Osteogenic sarcoma with clinically detectable metastases at initial presentation. J Clin Oncol. 1993;11:449–53.PubMed Meyers P, Heller G, Healey JH, et al. Osteogenic sarcoma with clinically detectable metastases at initial presentation. J Clin Oncol. 1993;11:449–53.PubMed
5.
Zurück zum Zitat Bacci G, Rocca M, Salone M, et al. High-grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol. 2008;98:415–20.PubMedCrossRef Bacci G, Rocca M, Salone M, et al. High-grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol. 2008;98:415–20.PubMedCrossRef
6.
Zurück zum Zitat Marina NM, Pratt CB, Bhaskar NR, et al. Improved prognosis of children with osteosarcoma metastatic to lung(s) at the time of diagnosis. Cancer. 1992;70:2722–7.PubMedCrossRef Marina NM, Pratt CB, Bhaskar NR, et al. Improved prognosis of children with osteosarcoma metastatic to lung(s) at the time of diagnosis. Cancer. 1992;70:2722–7.PubMedCrossRef
7.
Zurück zum Zitat Mankin HJ, Hornicek FJ, Temple HT, Gebhardt MC. Malignant tumors of the pelvis: an outcome study. Clin Orthop Relat Res. 2004;425:212–7.PubMedCrossRef Mankin HJ, Hornicek FJ, Temple HT, Gebhardt MC. Malignant tumors of the pelvis: an outcome study. Clin Orthop Relat Res. 2004;425:212–7.PubMedCrossRef
8.
Zurück zum Zitat Grimer RJ, Carter SR, Tillman RM, Spooner D, Mangham DC, Kabukcuoglu Y. Osteosarcoma of the pelvis. J Bone Joint Surg [Br] 1999;81-B:796–802. Grimer RJ, Carter SR, Tillman RM, Spooner D, Mangham DC, Kabukcuoglu Y. Osteosarcoma of the pelvis. J Bone Joint Surg [Br] 1999;81-B:796–802.
9.
Zurück zum Zitat Ozaki T, Flege S, Kevric M, et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol. 2003;21:334–41.PubMedCrossRef Ozaki T, Flege S, Kevric M, et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol. 2003;21:334–41.PubMedCrossRef
10.
Zurück zum Zitat Donati D, Giacomini S, Gozzi E, et al. Osteosarcoma of the pelvis. Eur J Surg Oncol. 2004;3:332–40.CrossRef Donati D, Giacomini S, Gozzi E, et al. Osteosarcoma of the pelvis. Eur J Surg Oncol. 2004;3:332–40.CrossRef
11.
Zurück zum Zitat Ferrari S, Palmerini E, Fabbri N, et al. Osteosarcoma of the pelvis. A monoinstitutional experience in patients younger than 41 years. Tumori. 2012;98(6):702–8.PubMed Ferrari S, Palmerini E, Fabbri N, et al. Osteosarcoma of the pelvis. A monoinstitutional experience in patients younger than 41 years. Tumori. 2012;98(6):702–8.PubMed
12.
Zurück zum Zitat Janinis J, McTiernan A, Driver D, et al. A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma. Ann Oncol. 2002;13:1935–44.PubMedCrossRef Janinis J, McTiernan A, Driver D, et al. A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma. Ann Oncol. 2002;13:1935–44.PubMedCrossRef
13.
Zurück zum Zitat Bielack SS, Wulff B, Delling G, et al. Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma Study Group. Med Ped Oncol. 1995;24:6–12.CrossRef Bielack SS, Wulff B, Delling G, et al. Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma Study Group. Med Ped Oncol. 1995;24:6–12.CrossRef
14.
Zurück zum Zitat Picci P, Bacci G, Campanacci M, et al. Histologic evaluation of necrosis induced by chemotherapy. Regional mapping of viable and nonviable tissue. Cancer. 1985;56:1515–21.PubMedCrossRef Picci P, Bacci G, Campanacci M, et al. Histologic evaluation of necrosis induced by chemotherapy. Regional mapping of viable and nonviable tissue. Cancer. 1985;56:1515–21.PubMedCrossRef
15.
Zurück zum Zitat Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241–6.PubMed Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241–6.PubMed
16.
Zurück zum Zitat Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef
17.
Zurück zum Zitat Conover WJ. Practical nonparametric statistics. New York: Wiley; 1980. p. 153–69. Conover WJ. Practical nonparametric statistics. New York: Wiley; 1980. p. 153–69.
18.
Zurück zum Zitat Bruland OS, Pihl A. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer. 1997;33:1725–31.PubMedCrossRef Bruland OS, Pihl A. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer. 1997;33:1725–31.PubMedCrossRef
19.
Zurück zum Zitat Morgan E, Baum E, Bleyer WA, et al. Treatment of patients with metastatic osteosarcoma: a report from the Children’s Cancer Study Group. Cancer Treat Rep. 1984;68:661–4.PubMed Morgan E, Baum E, Bleyer WA, et al. Treatment of patients with metastatic osteosarcoma: a report from the Children’s Cancer Study Group. Cancer Treat Rep. 1984;68:661–4.PubMed
20.
Zurück zum Zitat Patel SG, Meyers P, Huvos AG, et al. Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer. 2002;95(7):1495–503.PubMedCrossRef Patel SG, Meyers P, Huvos AG, et al. Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer. 2002;95(7):1495–503.PubMedCrossRef
21.
Zurück zum Zitat Granowski-LeCornu M, Chuang SK, Kaban LB, August M. Osteosarcoma of the jaws: factors influencing prognosis. J Oral Maxillofac Surg. 2011;69:2368–75.PubMedCrossRef Granowski-LeCornu M, Chuang SK, Kaban LB, August M. Osteosarcoma of the jaws: factors influencing prognosis. J Oral Maxillofac Surg. 2011;69:2368–75.PubMedCrossRef
22.
Zurück zum Zitat Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM. Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer. 2009;115:3262–70.PubMedCrossRef Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM. Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer. 2009;115:3262–70.PubMedCrossRef
23.
Zurück zum Zitat Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer. 2006;106:1154–61.PubMedCrossRef Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer. 2006;106:1154–61.PubMedCrossRef
24.
Zurück zum Zitat Kager L, Zoubek A, Pötschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003;21:2011–8.PubMedCrossRef Kager L, Zoubek A, Pötschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003;21:2011–8.PubMedCrossRef
25.
Zurück zum Zitat Voute PA, Souhami RL, Nooij M, et al. A phase II study of cisplatin, ifosfamide and doxorubicin in operable, primary, axial skeletal and metastatic osteosarcoma. Ann Oncol. 1999;10:1211–8.PubMedCrossRef Voute PA, Souhami RL, Nooij M, et al. A phase II study of cisplatin, ifosfamide and doxorubicin in operable, primary, axial skeletal and metastatic osteosarcoma. Ann Oncol. 1999;10:1211–8.PubMedCrossRef
26.
Zurück zum Zitat Saab R, Rao BN, Rodriguez-Galindo C, Billups CA, Fortenberry TN, Daw NC. Osteosarcoma of the pelvis in children and young adults: the St. Jude Children’s Research Hospital experience. Cancer. 2005;103:1468–74.PubMedCrossRef Saab R, Rao BN, Rodriguez-Galindo C, Billups CA, Fortenberry TN, Daw NC. Osteosarcoma of the pelvis in children and young adults: the St. Jude Children’s Research Hospital experience. Cancer. 2005;103:1468–74.PubMedCrossRef
27.
Zurück zum Zitat Hauben EI, Weeden S, Pringle J, Van Merck EA, Hogendoorn PC. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer. 2002;38:1218–25.PubMedCrossRef Hauben EI, Weeden S, Pringle J, Van Merck EA, Hogendoorn PC. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer. 2002;38:1218–25.PubMedCrossRef
28.
Zurück zum Zitat Bacci G, Bertoni F, Longhi A, et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histological response to preoperative chemotherapy correlates with histological subtype of the tumour. Cancer. 2003;97:3068–75.PubMedCrossRef Bacci G, Bertoni F, Longhi A, et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histological response to preoperative chemotherapy correlates with histological subtype of the tumour. Cancer. 2003;97:3068–75.PubMedCrossRef
29.
Zurück zum Zitat Schwarz R, Burland O, Cassoni A, Schomberg P, Bielack S. The role of radiotherapy in osteosarcoma. Cancer Treat Res. 2009;152:147–64.PubMedCrossRef Schwarz R, Burland O, Cassoni A, Schomberg P, Bielack S. The role of radiotherapy in osteosarcoma. Cancer Treat Res. 2009;152:147–64.PubMedCrossRef
30.
Zurück zum Zitat Ciernik IF, Niemierko A, Harmon DC, et al. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer. 2011;117:4522–30.PubMedCentralPubMedCrossRef Ciernik IF, Niemierko A, Harmon DC, et al. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer. 2011;117:4522–30.PubMedCentralPubMedCrossRef
Metadaten
Titel
Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents
verfasst von
Cristina Meazza
Roberto Luksch
Primo Daolio
Marta Podda
Alessandro Luzzati
Alessandro Gronchi
Antonina Parafioriti
Lorenza Gandola
Paola Collini
Andrea Ferrari
Michela Casanova
Monica Terenziani
Filippo Spreafico
Daniela Polastri
Veronica Biassoni
Elisabetta Schiavello
Emilia Pecori
Maura Massimino
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 4/2014
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0875-x

Weitere Artikel der Ausgabe 4/2014

Medical Oncology 4/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.